Back
Rocket Pharmaceuticals Stock Price Chart
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
50
RCKT
Rocket Pharmaceuticals
Last Price:
23.63
Seasonality Move:
26.74%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.74 | Sell |
| 20-day SMA: | 24.9 | Sell |
| 50-day SMA: | 27.01 | Sell |
| 200-day SMA: | 23.04 | Buy |
| 8-day EMA: | 23.86 | Sell |
| 20-day EMA: | 24.78 | Sell |
| 50-day EMA: | 26.08 | Sell |
| 200-day EMA: | 24.25 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.01 | Sell |
| Relative Strength Index (14 RSI): | 39.28 | Sell |
| Chaikin Money Flow: | -442546 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.91 - 26.85) | Sell |
| Bollinger Bands (100): | (25.4 - 29.56) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 23.67 while RCKT 8-day simple moving average is 23.74, which is a Sell signal.
- The stock price of RCKT is 23.67 while Rocket Pharmaceuticals 20-day SMA is 24.90, which makes it a Sell.
- Rocket Pharmaceuticals 50-day simple moving average is 27.01 while RCKT share price is 23.67, making it a Sell technically.
- RCKT stock price is 23.67 and Rocket Pharmaceuticals 200-day simple moving average is 23.04, creating a Buy signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
50
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $23.67. The Score for RCKT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
2.14B
Price in USD:
23.67
Share Volume:
450.74K
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
14.89
Sell
50
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 23.67 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 23.67 while RCKT 8-day exponential moving average is 23.86, which is a Sell signal.
- The stock price of RCKT is 23.67 while Rocket Pharmaceuticals 20-day EMA is 24.78, which makes it a Sell.
- Rocket Pharmaceuticals 50-day exponential moving average is 26.08 while RCKT share price is 23.67, making it a Sell technically.
- RCKT stock price is 23.67 and Rocket Pharmaceuticals 200-day simple moving average is 24.25, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -1.01, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 39.28, which suggest Rocket Pharmaceuticals is oversold
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (23.91 - 26.85), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (25.4 - 29.56), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.